Author:
Ibarra Arkaitz,Zhao Yue,Salathia Neeraj S.,Zhuang Jiali,Huang Vera,Acosta Alexander D.,Aballi Jonathan,Toden Shusuke,Karns Amy P.,Purnajo Intan,Parks Julianna R.,Guo Lucy,Mason James,Sigal Darren,Nova Tina S.,Quake Stephen R.,Nerenberg Michael
Abstract
AbstractCirculating cell free mRNA (cf-mRNA) holds great promise as a non-invasive diagnostic biomarker. However, the biological origin of cf-mRNA is still not well understood, limiting the clinical applications of this technology. Here, we use the bone marrow (BM) and pharmacologic manipulation of its resident cells as a window to study the origin of cf-mRNA. Using NGS-based profiling, we show that cf-mRNA is enriched in transcripts derived from the BM compared to circulating cells. Further, BM ablation experiments followed by hematopoietic stem cell transplants in cancer patients show that cf-mRNA levels reflect the transcriptional activity of BM resident hematopoietic lineages during marrow reconstitution. Finally, by stimulating specific BM cell populations in vivo using growth factor therapeutics (i.e. EPO, G-CSF), we show that cf-mRNA reveals dynamic functional changes in growing cell types, suggesting that, unlike other cell-free nucleic acids, cf-mRNA is secreted from living cells, rather than exclusively from apoptotic cells. Our results shed new light on the biology of cf-mRNA and demonstrate its potential applications in clinical practice.
Publisher
Cold Spring Harbor Laboratory